Budget Amount *help |
¥16,640,000 (Direct Cost: ¥12,800,000、Indirect Cost: ¥3,840,000)
Fiscal Year 2018: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2017: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2015: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
|
Outline of Final Research Achievements |
We have been developing an animal cell-displaying technology using the hypermutating B cell line DT40. In this study, we elucidated a function of a splicing factor, SRSF1, which we have previously found that is essential for hypermutation of the immunoglobulin gene, and developed a method to increase hypermutation efficiency by manipulation of SRSF1 expression.
|